Adjuvant Autolymphocyte Therapy (ALT) For Patients With Non-Metastatic Renal Cell Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Autolymphocyte therapy (Primary)
- Indications Renal cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2013 Biomarkers information updated
- 15 Dec 2009 Planned number of patients changed from 10 to 90 as reported by ClinicalTrials.gov.
- 15 Aug 2005 New trial record.